AML (Acute Myeloid Leukemia) Dual Inhibitor of Mutant Isocitrate Dehydrogenase (IDH) 1 and 2 in R/R Myeloid HM Patients Sep 04, 2023
AML (Acute Myeloid Leukemia),Leukemia First-In-Human Study of NEXI-001 for Relapsed AML Patients Aug 23, 2023
AML (Acute Myeloid Leukemia) Decitabine, Venetoclax, and Ponatinib Combination in CML and Ph+ AML Patients: Accelerated Phase to Blast Phase. Aug 21, 2023
Leukemia,Other Cancers Ibrutinib Versus Placebo in Patients With Early-Stage CLL: CLL12 Trial Results Aug 03, 2023
Leukemia,Other Cancers Resource Usage in 3L+ CML Patients on Asciminib or Bosutinib Evaluated Jul 17, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Ibrutinib-Rituximab and Chemoimmunotherapy Long-term Outcomes in CLL Jun 02, 2023
Leukemia Updated Results of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL May 30, 2023
